SCHEMBL9952304

SCHEMBL9952304

CCc1nccc(C(=O)O)n1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 9/20 0.49
KDM5A P29375 3/20 0.49
KDM3A Q9Y4C1 2/20 0.49
JMJD1C Q15652 1/20 0.49
ALOX15 P16050 3/20 0.43
TSHR P16473 2/20 0.43
TDP1 Q9NUW8 2/20 0.43
ACMSD Q8TDX5 1/20 0.43
ALDH1A1 P00352 5/20 0.41
MAPT P10636 2/20 0.41
KDM5B Q9UGL1 2/20 0.41
KDM6B O15054 1/20 0.41
TET3 O43151 1/20 0.41
KDM4A O75164 1/20 0.41
BBOX1 O75936 1/20 0.41
KDM5C P41229 1/20 0.41
ASPH Q12797 1/20 0.41
KDM4D Q6B0I6 1/20 0.41
TET2 Q6N021 1/20 0.41
ALKBH5 Q6P6C2 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14495134 0.85 ALDH1A1 (0.42) KDM4EKDM5AKDM3AJMJD1CALOX15
SCHEMBL2826624 0.83 ADORA3 (0.37) KDM4EKDM5AKDM3AJMJD1CTSHR
SCHEMBL18036607 0.82 KDM4E (0.50) KDM4EKDM5AKDM3AJMJD1CALOX15
SCHEMBL3281281 0.82 KDM4E (0.51) KDM4EKDM5AKDM3AJMJD1CALOX15
SCHEMBL7066012 0.81 ALDH1A1 (0.46) KDM4EKDM5AKDM3AJMJD1CALOX15
SCHEMBL25176793 0.81 KDM4E (0.49) KDM4EKDM5AKDM3AJMJD1CALOX15
SCHEMBL7368934 0.81 KDM4E (0.49) KDM4EKDM5AKDM3AJMJD1CALOX15
SCHEMBL31053756 0.81 KDM4E (0.49) KDM4EKDM5AKDM3AJMJD1CALOX15
SCHEMBL16015726 0.80 HCRTR1 (0.50) KDM4EKDM3AALOX15TSHRALDH1A1
SCHEMBL20988500 0.80 BRD4 (0.43) HPGDNPC1RAB9APOLBMAPK8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2654422-A1 BICYCLO[3.2.1]OCTYL AMIDE DERIVATIVES AND USES OF SAME H. Lundbeck A/S (DK) 2013-10-30 EP disclosed
WO-2012088365-A1 BICYCLO[3.2.1]OCTYL AMIDE DERIVATIVES AND USES OF SAME H. LUNDBECK A/S (DK) 2012-06-28 WO disclosed
US-20120095001-A1 SUBSTITUTED-1,3,8-TRIAZASPIRO[4.5]DECANE-2,4-DIONES MERCK SHARP & DOHME CORP. (US) 2012-04-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120095001-A1 SUBSTITUTED-1,3,8-TRIAZASPIRO[4.5]DECANE-2,4-DIONES HIF1AN, HIF1A, EGLN2 KDM4E 100/4885KDM5A 127/4885KDM3A 132/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.